Ipamorelin 10 mg

Cjc-1295 Ipamorelin Research and Mechanism

Cjc-1295 ipamorelin is a synthetic pentapeptide growth hormone secretagogue that acts as a selective agonist at the ghrelin receptor (GHSR-1a). According to research data from Peptpedia, ipamorelin is distinguished from other GHRPs by releasing growth hormone without meaningfully elevating cortisol, prolactin, or ACTH at therapeutic doses — a selectivity profile unique among its class.citeweb_search:23#0 It mimics the action of natural ghrelin but with higher selectivity, stimulating GH release in a dose-dependent manner while maintaining the natural pulsatile pattern of GH secretion.

Research published in Loti Labs indicates that ipamorelin has a half-life of approximately 2 hours, longer than GHRP-6’s 20 to 30 minutes, and produces cleaner, more physiological GH pulses with minimal off-target effects.citeweb_search:23#3 A foundational study by Raun et al. (1998) established ipamorelin as the first selective growth hormone secretagogue, demonstrating dose-dependent GH release without significant effects on ACTH, cortisol, or prolactin.citeweb_search:23#0 It is critical to emphasise that ipamorelin is not approved by the TGA for human use. It is sold strictly for in vitro and laboratory research use only.

Ipamorelin Dosage and Reconstitution

Dose of Ipamorelin for Research Protocols

For laboratory research, ipamorelin is typically supplied as a 2mg lyophilised powder. According to research protocol references, typical laboratory dosing ranges from 200 to 300 micrograms per administration in preclinical models, with 2 to 3 daily doses to model physiological pulsatility.citeweb_search:23#2 For in vitro applications, working concentrations of 10 to 100 nanomolar are common reference points for studying GHS-R1a receptor signalling and pituitary cell responses. When studied in combination with CJC-1295 no DAC, a typical research protocol uses 100 micrograms CJC-1295 with 200 micrograms ipamorelin per administration.citeweb_search:23#2 Gently swirl the vial until fully dissolved. Do not shake vigorously. Allow the solution to settle at room temperature before aliquoting.

Dosing for Ipamorelin Reconstitution Guide

Remove the vial from freezer storage and allow it to equilibrate to room temperature for 15 to 20 minutes. Draw 1.0 to 2.0 mL of bacteriostatic water into a sterile syringe and inject slowly down the inner vial wall to minimise foaming. Gently swirl until fully dissolved. Label with the reconstitution date and store at 2 to 8 degrees C protected from light. Use within 14 to 21 days. Do not freeze reconstituted solution.

Ipamorelin Side Effects in Research Literature

According to Huddle Mens Health, ipamorelin is generally considered safe and well-tolerated in research contexts, with most subjects experiencing minimal adverse effects.citeweb_search:23#2 Common side effects documented in clinical literature include headaches, joint pain, temporary fatigue, water retention, injection site reactions, and tingling sensations.citeweb_search:23#2 Unlike GHRP-6 and GHRP-2, ipamorelin does not significantly increase appetite, cortisol, or prolactin.citeweb_search:23#0web_search:23#3 A small number of subjects may experience mild nausea or lightheadedness during initial administration. These safety profiles are documented for research reference only and do not constitute medical guidance.

How Ipamorelin Compares to Other Research Compounds

Ipamorelin vs GHRP-2

GHRP-2 is a first-generation hexapeptide growth hormone-releasing peptide that produces the highest peak GH release among traditional GHRPs. According to comparative research data, GHRP-2 achieves peak plasma GH concentrations of 30 to 100 ng/mL within 15 to 30 minutes, representing 8 to 20 fold increases above baseline.citeweb_search:23#1 However, GHRP-2 produces moderate cortisol and prolactin elevation comparable to hCRH. Ipamorelin produces moderate GH release with no significant cortisol, prolactin, or ACTH elevation. For researchers requiring maximum GH pulse amplitude with manageable hormonal co-effects, GHRP-2 may be preferable. For researchers requiring clean, selective GH stimulation without metabolic disruption, ipamorelin is the superior tool.

Ipamorelin vs GHRP-6

GHRP-6 is the original first-generation GHRP with the strongest appetite-stimulating effect of any growth hormone secretagogue. According to Loti Labs comparison data, GHRP-6 produces intense hunger, moderate cortisol increase, and moderate prolactin elevation.citeweb_search:23#3 Ipamorelin produces comparable GH release with minimal appetite stimulation, no cortisol increase, and no prolactin increase. GHRP-6 is studied when appetite stimulation is a desired research outcome. Ipamorelin is studied when selective GH release without metabolic side effects is the primary research goal. For most research contexts, ipamorelin is the cleaner starting point.

Ipamorelin vs CJC-1295 No DAC

CJC-1295 no DAC is a GHRH analog that activates the GHRH receptor on pituitary somatotroph cells. Ipamorelin is a ghrelin receptor agonist that activates GHS-R1a. According to research protocol data, combining CJC-1295 no DAC with ipamorelin produces synergistic GH pulses two to three times greater than either agent alone.citeweb_search:23#2 CJC-1295 no DAC provides the GHRH signal; ipamorelin provides the ghrelin signal. Together they model the dual physiological drive for GH secretion. For combined GH axis research, the CJC-1295 no DAC plus ipamorelin stack is the most studied combination.

Ipamorelin vs 5 Amino 1mq

5 amino 1mq is a small molecule NNMT inhibitor studied for metabolic regulation through NAD+ and SIRT1 pathways in adipose tissue. Ipamorelin is a peptide-based ghrelin receptor agonist studied for GH axis stimulation. 5 amino 1mq addresses cellular energy balance; ipamorelin addresses endocrine signalling. They are not interchangeable research compounds.

Ipamorelin vs AOD-9604

AOD-9604 is a modified HGH fragment studied for direct lipolysis via beta-3 adrenergic receptor pathways. Ipamorelin is a GH secretagogue that stimulates endogenous GH release through ghrelin receptor activation. AOD-9604 is positioned for fat metabolism research; ipamorelin is positioned for GH axis physiology research. They operate through entirely different mechanisms.

Ipamorelin vs MOTS-c

MOTS-c is a mitochondrial-derived peptide that activates AMPK and regulates cellular energy homeostasis. Ipamorelin is a hypothalamic-pituitary signalling peptide that activates the ghrelin receptor. MOTS-c is studied for metabolic adaptation; ipamorelin is studied for endocrine axis stimulation. These are entirely different research categories.

Ipamorelin vs Hgh Fragment 176 191

Hgh fragment 176 191 is a peptide fragment targeting the lipolytic domain of human growth hormone, studied for fat metabolism without IGF-1 effects. Ipamorelin is a GH secretagogue that stimulates endogenous GH and IGF-1 release. Hgh fragment 176 191 is investigated for subcutaneous fat reduction; ipamorelin is investigated for GH axis physiology. They are distinct research tools.

Cjc 1295 and Ipamorelin Dosing Research

Researchers frequently investigate cjc 1295 and ipamorelin dosing combinations because the two compounds act through complementary mechanisms. CJC-1295 no DAC activates the GHRH receptor to stimulate endogenous GH release, while ipamorelin activates the ghrelin receptor (GHS-R1a) in the pituitary. According to research protocol data, this dual-receptor approach produces synergistic GH elevation while maintaining more physiological pulse patterns than either compound alone.citeweb_search:23#2 Typical research protocols use 100 micrograms CJC-1295 no DAC with 200 micrograms ipamorelin per administration, 1 to 3 times daily depending on the study design. For researchers studying GH axis responsiveness, the combination offers a more complex signalling model than single-agent protocols.

Product Specifications

Purity and Analysis

• Content: 2mg lyophilised powder
• Sequence: Aib-His-D-2Nal-D-Phe-Lys-NH2
• Molecular Formula: C38H49N9O5
• Molecular Weight: 711.9 g/mol
• Purity: Greater than or equal to 98% by HPLC
• Appearance: White to off-white lyophilised powder
• Source: Synthetic, manufactured via solid-phase peptide synthesis

Each batch is independently tested. Request the Certificate of Analysis (COA) for your specific batch number to verify purity, mass spec, and chromatography data.

Storage and Handling

• Lyophilised storage: -20 degrees C, protected from light and moisture
• Shelf life (unreconstituted): 24 months when stored correctly
• Handling: Use sterile technique. Avoid repeated freeze-thaw cycles

Shipping and Returns

We ship ipamorelin from our Australian facility via express domestic courier. Orders placed before 2:00 PM AEST dispatch the same business day. All peptide orders are packaged in insulated, discreet packaging with cold-chain protection where required.

• • Minimum order: $200 AUD
  • Free shipping: Orders over $200 AUD
  • Flat rate: $15 AUD for orders under $200
  • Delivery time: 1 to 5 business days Australia-wide

<li